JRJan M. H. Risser

Jan M. H. Risser

*This is an algorithmically generated author record based on publicly available information.

Jan M. H. Risser has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • William L. Risser

    Department of Pediatrics, University of Texas Medical School at Houston, 6431 Fannin Street, Houston, TX 77030, USA

    3 shared publications
  • Alice Cates

    1 shared publication
  • Amanda L. Risser

    Department of Family Medicine, Oregon Health and Science University School of Medicine, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA

    1 shared publication
  • Hafeez Rehman

    1 shared publication
  • M Wolverton

    Houston Department of Health and Human Services, 9000 North Stadium Drive, Fourth Floor

    1 shared publication
  • Mark L. Williams

    WHO Center for Health Promotion and Prevention Research, University of Texas School of Public Health, Houston Health Science Center, Houston, Texas, USA

    1 shared publication

Latest Publications

  • Gender Differences in Social Support and Depression among Injection Drug Users in Houston, Texas

    by Jan Risser, Alice Cates, Hafeez Rehman, William Risser

    Background: Injection drug is the second most frequent HIV/AIDS exposure in the United States. Social support and depression may mediate risky behaviors among drug injectors. Objectives: To describe differences in perceived social support and depressive symptoms between male and female injection drug users, and to describe factors associated with depressive symptoms. Methods: Using respondent-driven sampling, we recruited and interviewed injection drug users in Houston, Texas. Data were from the Centers for Disease Control and Prevention's National HIV Behavioral Surveillance Program. We used the short Center for Epidemiologic Studies Depression Scale (CES-D 10) and scales for perceived social support from family, friends, and significant others from the Multidimensional Scale of Perceived Social Support. Four-hundred seventy-one participants had complete data and were included in this analysis. Results: Seventy-five percent of male and female participants had CES-D scores indicating depressive symptoms. In a multivariate logistic regression, depressive symptoms among men were positively associated with frequent use of speedballs (injecting heroin and cocaine together) and never having tested for HIV, and negatively associated with perceived social support from a special person. Among women, depressive symptoms were positively associated with currently smoking cigarettes, having no health insurance, and more years of injection drug use, and negatively associated with perceived social support from a special person. Conclusions: Lack of social support from a special person or significant other was associated with depressive symptoms in both males and females. Our findings suggest that depression and social support should be addressed when developing HIV prevention programs among injection drug users.


  • Relationship between heterosexual anal sex, injection drug use and HIV infection among black men and women

    by J M H Risser, P Padgett, M Wolverton, W L Risser

    US blacks carry a disproportionate risk of heterosexually transmitted HIV. This study aimed to evaluate the association between self-reported heterosexual anal intercourse and HIV. Using respondent-driven sampling (RDS), we recruited and interviewed 909 blacks from areas of high poverty and HIV prevalence in Houston, Texas, and who reported heterosexual sex in the last year. All individuals were tested for HIV. Weighted prevalence values were calculated to account for non-random recruitment associated with RDS. The weighted population prevalence of HIV infection was 2.4% and 2.5% among men and women, respectively. Education, employment status, income and crack cocaine use were not associated with HIV infection. Lifetime injection drug use (odds ratio [OR] 3.31, 95% confidence interval [CI] 1.31–8.33%) and heterosexual anal intercourse (OR 2.41, 95% CI 1.02–5.73%) were associated with HIV infection. Individuals who reported both injection drug use and heterosexual anal intercourse had 6.21 increased odds of HIV (95% CI 2.47–15.61%). Our results suggest that heterosexual anal sex may be a vector for HIV transmission, especially in the context of injection drug use. Prevention strategies directed at curbing the HIV epidemic among black heterosexuals require that we correctly identify the risks so that appropriate interventions can be developed.


  • Epidemiology of Infections in Women

    by Jan M.H. Risser, William L. Risser, Amanda L. Risser


  • Psychological Correlates of Trading Sex for Money Among African American Crack Cocaine Smokers

    by Jan M. H. Risser, Sandra C. Timpson, Sheryl A. McCurdy, Michael W. Ross, Mark L. Williams

    This article compares demographic characteristics, sexual practices, and psychosocial status among 193 African American female crack cocaine users who currently, previously, or never traded sex for money. Current traders were less likely to have a main sexual partner, more likely to have a casual sexual partner, and more likely to smoke larger quantities of crack. There was a significant trend towards current traders reporting lower self-esteem, greater depression and anxiety, poorer decision-making confidence, more hostility, less social conformity, greater risk taking behaviors, and more problems growing up, compared to previous and never traders. These differences suggest that interventions should address self-esteem, risk-taking practices, depression and anxiety as well as other psychosocial factors.


    • 1 February 2002
      • Vol. 98  (2) , 36-40

    Pelvic inflammatory disease in adolescents: a review.

    by William L Risser, Jan M H Risser, Polly F Cromwell

    Pelvic inflammatory disease is relatively common in sexually active adolescents. Most cases are only mildly symptomatic, and criteria for diagnosis should not be stringent. Although chlamydial or gonorrheal infections or both are common in pelvic inflammatory disease, other aerobic and anaerobic organisms are often also present and may be the only causative agents. Commonly used initial therapy, e.g., ceftriaxone and doxycycline, treats some but not all of these organisms. Patients should be seen within 48 to 72 hours after initiating therapy; lack of improvement suggests noncompliance with antibiotic therapy, the need for broader-spectrum antibiotic coverage, a tubo-ovarian abscess, or a mistake in diagnosis. Important preventive measures include screening of sexually active, asymptomatic adolescents for gonorrheal and chlamydial infections, not only in clinics for sexually transmitted diseases and family planning but also in primary care settings. Urine tests that amplify chlamydial and gonococcal nucleic acid are noninvasive and very accurate.